Welcome to the BOC Translational Hub

The Translational Hub is an initiative of the Breast Oncology Program at the Dana-Farber Brigham Cancer Center, established to support the collection, processing, and storage of biospecimens from patients enrolled in clinical studies. Our goal is to facilitate biospecimen collection and provide investigators with optimal samples to conduct the highest-quality translational research.

The Translational Hub aims to bring together investigators and clinical and research staff to unify our experience, expertise, and efforts in support of this mission. This purpose aligns with Dana-Farber’s mission to understand, treat, cure, and prevent cancer.

Interviews Featuring Dr. Mittendorf

Key Takeaways from IMpassion131 (ESMO 2020)

Dr. Mittendorf discusses key takeaways from the IMpassion131 clinical trial investigating first-line atezolizumab in combination with chemotherapy in metastatic triple-negative breast cancer (TNBC), presented at the 2020 ESMO Virtual Congress.

Watch: Elizabeth Mittendorf, MD, PhD, considers key takeaways from the Impassion-131 presented at ESMO 2020 on the OBROncology YouTube Channel

Susan F. Smith Center Executive Council Beyond Boston Luncheon (2019)

Enjoy highlights from the 2019 Susan F. Smith Center Executive Council Beyond Boston Luncheon, featuring Dr. Mittendorf discussing the success of the Women’s Breast Program.

Building on Recent Successes

Dr. Mittendorf discusses advances in breast cancer immunotherapy.
Watch: Elizabeth A. Mittendorf, MD, PhD, on Breast Cancer Immunotherapy: Building on Recent Successes (OncLive YouTube Channel)

Immunotherapy Efforts in Breast Cancer​

Dr. Mittendorf discusses immunotherapy efforts in breast cancer.

Watch: Dr. Mittendorf Discusses Immunotherapy Efforts in Breast Cancer (OncLive YouTube Channel)

Updating the AJCC Staging System

Watch: Dr. Mittendorf Discusses Rationale for Updating AJCC Staging System (OncLive YouTube Channel)

Tweets by @EMittendorfMD